ARTICLE | Company News
AstraZeneca, Serono deal
July 29, 2002 7:00 AM UTC
AZN granted SRA exclusive worldwide rights to develop and market anastrozole for ovulation induction and improvement of follicular development as a first-line therapy for infertility. SRA plans to beg...